Table 2:
Associations of PWV measures, derived CAVI, and derived CFVI with the risk of cardiovascular events
Characteristics | Q1 | Q2 | Q3 | Q4 | ||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | P* | HR (95% CI) | P* | HR (95% CI) | P* | |||
Central arterial stiffness | ||||||||
cfPWV | Model 1 | 1.66 (0.96, 2.84) | 0.07 | ref | 2.20 (1.31, 3.69) | 0.003 | 2.54 (1.53, 4.21) | <0.001 |
Model 2 | 1.80 (1.05, 3.10) | 0.03 | ref | 2.01 (1.20, 3.39) | 0.01 | 2.05 (1.23, 3.43) | 0.01 | |
Model 3 | 2.03 (1.17, 3.50) | 0.01 | ref | 2.02 (1.20, 3.41) | 0.01 | 1.91 (1.13, 3.23) | 0.02 | |
Model 4 | 1.97 (1.14, 3.39) | 0.02 | ref | 1.96 (1.16, 3.31) | 0.01 | 1.83 (1.08, 3.09) | 0.02 | |
hfPWV | Model 1 | 1.16 (0.71, 1.88) | 0.56 | ref | 1.21 (0.75, 1.97) | 0.44 | 1.74 (1.11, 2.73) | 0.02 |
Model 2 | 1.28 (0.78, 2.08) | 0.33 | ref | 1.09 (0.67, 1.78) | 0.72 | 1.37 (0.86, 2.18) | 0.19 | |
Model 3 | 1.33 (0.81, 2.17) | 0.26 | ref | 1.04 (0.63, 1.69) | 0.89 | 1.26 (0.78, 2.03) | 0.35 | |
Model 4 | 1.33 (0.81, 2.17) | 0.26 | ref | 1.04 (0.64, 1.70) | 0.87 | 1.19 (0.73, 1.93) | 0.48 | |
Derived CFVI | Model 1 | 1.38 (0.83, 2.28) | 0.21 | ref | 1.49 (0.91, 2.46) | 0.12 | 1.97 (1.23, 3.17) | 0.01 |
Model 2 | 1.46 (0.88, 2.41) | 0.15 | ref | 1.29 (0.78, 2.13) | 0.32 | 1.47 (0.90, 2.40) | 0.13 | |
Model 3 | 1.51 (0.91, 2.50) | 0.11 | ref | 1.25 (0.75, 2.07) | 0.39 | 1.36 (0.83, 2.24) | 0.22 | |
Model 4 | 1.51 (0.91, 2.51) | 0.11 | ref | 1.24 (0.75, 2.06) | 0.39 | 1.30 (0.79, 2.14) | 0.30 | |
Composite arterial stiffness | ||||||||
baPWV | Model 1 | 0.89 (0.54, 1.45) | 0.63 | ref | 1.51 (0.98, 2.34) | 0.06 | 1.45 (0.93, 2.25) | 0.10 |
Model 2 | 1.02 (0.62, 1.67) | 0.94 | ref | 1.40 (0.90, 2.17) | 0.13 | 1.21 (0.77, 1.90) | 0.40 | |
Model 3 | 1.10 (0.67, 1.82) | 0.70 | ref | 1.34 (0.86, 2.08) | 0.19 | 1.13 (0.71, 1.81) | 0.59 | |
Model 4 | 1.09 (0.66, 1.80) | 0.73 | ref | 1.35 (0.87, 2.09) | 0.18 | 1.12 (0.70, 1.78) | 0.64 | |
haPWV | Model 1 | 1.09 (0.67, 1.77) | 0.73 | ref | 1.16 (0.72, 1.87) | 0.55 | 1.52 (0.96, 2.40) | 0.07 |
Model 2 | 1.21 (0.75, 1.98) | 0.44 | ref | 1.07 (0.66, 1.73) | 0.79 | 1.21 (0.76, 1.92) | 0.43 | |
Model 3 | 1.28 (0.78, 2.09) | 0.33 | ref | 1.03 (0.63, 1.67) | 0.91 | 1.14 (0.70, 1.85) | 0.61 | |
Model 4 | 1.28 (0.78, 2.09) | 0.33 | ref | 1.00 (0.62, 1.63) | 0.99 | 1.10 (0.67, 1.80) | 0.70 | |
Derived CAVI | Model 1 | 1.07 (0.66, 1.74) | 0.77 | ref | 1.30 (0.82, 2.07) | 0.26 | 1.38 (0.87, 2.18) | 0.17 |
Model 2 | 1.12 (0.69, 1.81) | 0.66 | ref | 1.10 (0.69, 1.75) | 0.69 | 0.97 (0.60, 1.56) | 0.89 | |
Model 3 | 1.13 (0.69, 1.84) | 0.62 | ref | 1.08 (0.67, 1.72) | 0.76 | 0.95 (0.59, 1.54) | 0.84 | |
Model 4 | 1.12 (0.68, 1.82) | 0.66 | ref | 1.07 (0.67, 1.72) | 0.76 | 0.94 (0.58, 1.52) | 0.80 |
Model 1: Crude
Model 2: Age, sex, race
Model 3: Model 2 + education, current smoking, body mass index, history of diabetes, mean arterial pressure, antihypertensive medication, total cholesterol, high-density lipoprotein
Model 4: Model 3 + ankle brachial index, estimated glomerular filtration rate, albumin-creatinine ratio
HR=hazard ratio; Q1, Q2, Q3, Q4=quartile 1, quartile 2, quartile 3, quartile 4
P-values test quartile-specific estimates vs. the referent (quartile 2)